The conventional fabrication process of 32P-based applicators involves dripping a 32P solution onto filter paper that conforms to the shape of the lesion, followed by drying. However, this approach has several critical drawbacks: (1) it is a time-consuming process, (2) non-uniform radionuclide distribution due to random droplet placement, which can result in localized excessive or insufficient dosage, (3) up to 50% loss of the 32P radionuclide during the drying process, and the generation of radioactive aerosols that pose a risk to health.